CSIMarket Company Name, Ticker, Customers, else..
 
Stoke Therapeutics Inc   (NASDAQ: STOK)
 

Stoke Therapeutics Inc's Suppliers Performance

STOK's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
STOK Costs vs Sales of Suppliers Growth

• More on STOK Suppliers






Stoke Therapeutics Inc's Comment on Supply Chain


The company consolidates raw material procurement and drug substance manufacturing with a single supplier while planning to establish supply agreements with alternative suppliers to ensure supply chain continuity. It invests in process improvements to enhance purity and yield and may expand capabilities with existing contractors or establish new manufacturing supply relationships as needed. Internal personnel identify and establish relationships with contractors suited for new manufacturing requirements. For drug products, the company anticipates oligonucleotide formulations will be produced using common processes and readily available materials and is establishing agreements with various contractors capable of manufacturing, packaging, and testing these formulations for clinical and commercial use.

Stoke Therapeutics Inc's Comment on Supply Chain


The company consolidates raw material procurement and drug substance manufacturing with a single supplier while planning to establish supply agreements with alternative suppliers to ensure supply chain continuity. It invests in process improvements to enhance purity and yield and may expand capabilities with existing contractors or establish new manufacturing supply relationships as needed. Internal personnel identify and establish relationships with contractors suited for new manufacturing requirements. For drug products, the company anticipates oligonucleotide formulations will be produced using common processes and readily available materials and is establishing agreements with various contractors capable of manufacturing, packaging, and testing these formulations for clinical and commercial use.







STOK's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Stoke Therapeutics Inc 1,851.80 27.59 -207.90 170
SUBTOTAL 0.00 0.00 0.00 -


Sources: Stoke Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Stoke Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.